Evidence map›Paper›PMID 40221542›Full record

ArticleScientific reports2025

Immune cell phenotypes as causal factors in liver disease progression revealed by Mendelian randomization.

Jingtao Huang, Wenlu Zou, Zhihua Lv, Huan Han, Jiapeng Huang, Hanwen Su

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jingtao Huang *Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Wenlu Zou *Department of Infectious Diseases, Qilu Hospital of Shandong University, Wenhua Xi Road 107, Jinan, 250012, Shandong, China.
Zhihua LvDepartment of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Huan HanDepartment of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Jiapeng HuangDepartment of Thyroid Surgery, The First Hospital of China Medical University, No. 155 in Nanjing North Street, Heping Distinct, Shenyang, Liaoning, China. huangjiapeng499@163.com.
Hanwen SuDepartment of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China. hanwensu@whu.edu.cn.

Funding

Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University JCRCFZ-2022-023National Key R&D Program of China 2023YFC2308404National Natural Science Foundation of China 82372232Natural Science Foundation of Hubei Province 2022CFB127Natural Science Foundation of Liaoning Province 2023-MS-156the National Natural Science Foundation of China 82303670the Traditional Chinese Medicine project of Hubei Province's Health Commission ZY2023M022
6 · The paper itself

Abstract

Immune cells are central mediators of the immune response and play critical roles in the pathogenesis and progression of liver diseases. Understanding the specific contributions of immune cells to liver disease progression is essential for developing targeted therapeutic strategies. In this study, we employed a two-sample Mendelian randomization (MR) approach to explore potential causal relationships between peripheral immune cell phenotypes and liver diseases, using genetic instrumental variables from large-scale genome-wide association studies (GWAS). Applying the inverse variance weighted (IVW) methods, we identified that monocyte count(odds ratio (OR) 0.81; 95% confidence interval (CI) 0.74-0.90; P  =  5.95 × 10

Indexed as

Liver DiseasesMendelian Randomization AnalysisDisease ProgressionGenome-Wide Association StudyHumansKiller Cells, NaturalMonocytesPhenotypeImmune cellsLiver diseasesMendelian randomizationWhite blood cells

Identifiers

PMID40221542
PMCPMC11993735

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.